Archives: Search / 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015
2013 Archives
Philadelphia, PA – December 19, 2013 – Lannett Company, Inc. (NYSE: LCI) today announced that it has established a new, five-year $50 million revolving credit facility with a syndicate... More |
Philadelphia, PA – December 3, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the Oppenheimer 24th Annual Healthcare Conference on... More |
Philadelphia, PA – December 2, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that it will transfer the listing of its common stock to the New York Stock Exchange (NYSE)... More |
Adjusted EPS of $0.22 Exceeds Expectations;
Company Revises Fiscal 2014 Guidance Upward
|
Company to Report Full Financial Results, Host Conference Call on Thursday, November 7th Philadelphia, PA – October 31, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that it expects to report fiscal 2014 first quarter net sales of approximately $45 million... More |
Philadelphia, PA – October 9, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) has closed its previously announced underwritten public offering of 5,869,566 shares of the Company’s... More |
Company Completes Key Step in Process to Submit Product Application Philadelphia, PA – October 8, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that it has successfully completed a key step in its effort to submit to the U.S. Food and... More |
Philadelphia, PA – October 4, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced the pricing of an underwritten public offering of 5,869,566 shares of the Company’s common... More |
Philadelphia, PA – October 3, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that it and certain selling stockholders intend to offer shares of the Company’s common... More |
Philadelphia, PA – September 10, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today reported financial results for its fiscal 2013 fourth quarter and full year ended June 30, 2013. For... More |
Philadelphia, PA – August 29, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that it will report financial results for its fiscal 2013 fourth quarter and full year on... More |
Philadelphia, PA – August 19, 2013 – Lannett Company, Inc. (NYSE MKT: LCI), a manufacturer of generic pharmaceuticals, today announced that it has extended its contract with Jerome... More |
Philadelphia, PA – August 9, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the Canaccord Genuity 33rd Annual Growth Conference on... More |
Philadelphia, PA – June 3, 2013 – Lannett Company, Inc. (NYSE MKT: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of James M. Maher to its Board of... More |
Net Sales Increase 27%; Net Income More than Doubles;
Company Increases Guidance for Full Year
|
Philadelphia, PA – April 23, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the Needham’s 12th Annual Healthcare Conference on... More |
Philadelphia, PA – March 12, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the 25th Annual Roth Conference on Monday, March 18, 2013, at... More |
Growth Momentum Continues with 32% Sales Increase;
Company Increases Guidance for Full Year Philadelphia, PA – February 7, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today reported continued strong momentum, with sharply improved financial results for its fiscal 2013 second... More |
Net sales and eps up sharply from prior year period Philadelphia, PA – January 31, 2013 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that it expects to report net sales of approximately $36 million and diluted earnings per... More |